• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Eosinophilic fasciitis in association with nivolumab: The importance of eosinophilia.

作者信息

Pabón-Cartagena Gabriela, López Andrea, Watts Erika, Alonso Norma

机构信息

Transitional Year Program, University of Puerto Rico School of Medicine, San Juan, Puerto Rico.

University of Puerto Rico School of Medicine, San Juan, Puerto Rico.

出版信息

JAAD Case Rep. 2020 Apr 25;6(12):1303-1306. doi: 10.1016/j.jdcr.2020.04.017. eCollection 2020 Dec.

DOI:10.1016/j.jdcr.2020.04.017
PMID:33294570
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7700974/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6933/7700974/c49598a70836/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6933/7700974/354f666d6693/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6933/7700974/c49598a70836/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6933/7700974/354f666d6693/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6933/7700974/c49598a70836/gr2.jpg

相似文献

1
Eosinophilic fasciitis in association with nivolumab: The importance of eosinophilia.与纳武单抗相关的嗜酸性筋膜炎：嗜酸性粒细胞增多的重要性。
JAAD Case Rep. 2020 Apr 25;6(12):1303-1306. doi: 10.1016/j.jdcr.2020.04.017. eCollection 2020 Dec.
2
Serum levels of tissue inhibitor of metalloproteinase-1 and 2 in patients with eosinophilic fasciitis.嗜酸性筋膜炎患者血清金属蛋白酶组织抑制剂-1和-2水平
Br J Dermatol. 2004 Aug;151(2):407-12. doi: 10.1111/j.1365-2133.2004.06062.x.
3
High-Dose Intravenous Pulse Methotrexate in Patients With Eosinophilic Fasciitis.高剂量静脉注射甲氨蝶呤治疗嗜酸性筋膜炎患者。
JAMA Dermatol. 2016 Nov 1;152(11):1262-1265. doi: 10.1001/jamadermatol.2016.2873.
4
Eosinophilic fasciitis: clinical characteristics and response to methotrexate.嗜酸性筋膜炎：临床特征及对甲氨蝶呤的反应
Int J Rheum Dis. 2015 Jan;18(1):91-8. doi: 10.1111/1756-185X.12499. Epub 2014 Dec 20.
5
An Original Case of an Association of Eosinophilic Fasciitis with Cholangitis Induced by Nivolumab.1例嗜酸性筋膜炎合并纳武单抗诱发胆管炎的原始病例。
J Thorac Oncol. 2019 Jan;14(1):e13-e15. doi: 10.1016/j.jtho.2018.09.016.
6
Eosinophilic Fasciitis Triggered by Nivolumab: A Remarkable Efficacy of the mTOR Inhibitor Sirolimus.由纳武单抗引发的嗜酸性筋膜炎：mTOR抑制剂西罗莫司的显著疗效
J Thorac Oncol. 2020 Feb;15(2):e29-e30. doi: 10.1016/j.jtho.2019.09.011.
7
Eosinophilic Fasciitis: an Updated Review on Diagnosis and Treatment.嗜酸性筋膜炎：诊断与治疗的最新综述。
Curr Rheumatol Rep. 2017 Nov 4;19(12):74. doi: 10.1007/s11926-017-0700-6.
8
Eosinophilic fasciitis and eosinophilic cellulitis in a patient with abnormal circulating clonal T cells: increased production of interleukin 5 and inhibition by interferon alfa.一名循环克隆性T细胞异常患者的嗜酸性筋膜炎和嗜酸性蜂窝织炎：白细胞介素5产生增加及α干扰素的抑制作用
J Am Acad Dermatol. 2003 Dec;49(6):1170-4. doi: 10.1016/s0190-9622(03)00447-x.
9
A Literature Review of Eosinophilic Fasciitis with an Illustrative Case.嗜酸性筋膜炎文献综述及病例展示
Curr Rheumatol Rev. 2017;13(2):113-120. doi: 10.2174/1573397112666161007154703.
10
The use of tocilizumab in the treatment of refractory eosinophilic fasciitis: a case-based review.托珠单抗治疗难治性嗜酸性筋膜炎：基于病例的综述。
Clin Rheumatol. 2020 May;39(5):1693-1698. doi: 10.1007/s10067-020-04952-5. Epub 2020 Jan 23.

引用本文的文献

1
Review of T Helper 2-Type Inflammatory Diseases Following Immune Checkpoint Inhibitor Treatment.免疫检查点抑制剂治疗后2型辅助性T细胞炎症性疾病的综述
Biomedicines. 2024 Aug 19;12(8):1886. doi: 10.3390/biomedicines12081886.
2
Eosinophilic Fasciitis: Current and Remaining Challenges.嗜酸性筋膜炎：现状与遗留挑战。
Int J Mol Sci. 2023 Jan 19;24(3):1982. doi: 10.3390/ijms24031982.
3
Eosinophilic Fasciitis with Concurrent Necrobiotic Granulomatous Dermatitis Related to Checkpoint Inhibition Therapy.伴有坏死性肉芽肿性皮炎的嗜酸性筋膜炎与检查点抑制疗法相关

本文引用的文献

1
Eosinophilic fasciitis: From pathophysiology to treatment.嗜酸性筋膜炎：从病理生理学到治疗。
Allergol Int. 2019 Oct;68(4):437-439. doi: 10.1016/j.alit.2019.03.001. Epub 2019 Mar 22.
2
An Original Case of an Association of Eosinophilic Fasciitis with Cholangitis Induced by Nivolumab.1例嗜酸性筋膜炎合并纳武单抗诱发胆管炎的原始病例。
J Thorac Oncol. 2019 Jan;14(1):e13-e15. doi: 10.1016/j.jtho.2018.09.016.
3
Skin Reactions to Immune Checkpoint Inhibitors.皮肤对免疫检查点抑制剂的反应。
J Immunother Precis Oncol. 2022 Jan 20;5(2):48-51. doi: 10.36401/JIPO-21-19. eCollection 2022 May.
Adv Exp Med Biol. 2018;995:117-129. doi: 10.1007/978-3-030-02505-2_5.
4
Eosinophilic fasciitis and lichen sclerosus in a patient treated with nivolumab.一名接受纳武单抗治疗的患者出现嗜酸性筋膜炎和硬化性苔藓。
Australas J Dermatol. 2018 Nov;59(4):e302-e304. doi: 10.1111/ajd.12836. Epub 2018 May 24.
5
Autoimmune fasciitis triggered by the anti-programmed cell death-1 monoclonal antibody nivolumab.由抗程序性细胞死亡-1单克隆抗体纳武单抗引发的自身免疫性筋膜炎。
BMJ Case Rep. 2018 Feb 8;2018:bcr-2017-223249. doi: 10.1136/bcr-2017-223249.
6
Bullous Pemphigoid-like Skin Lesions and Overt Eosinophilia in a Patient With Melanoma Treated With Nivolumab: Case Report and Review of the Literature.大疱性类天疱疮样皮肤病变和明显嗜酸性粒细胞增多症在接受纳武利尤单抗治疗的黑色素瘤患者中：病例报告及文献复习。
J Immunother. 2018 Apr;41(3):164-167. doi: 10.1097/CJI.0000000000000210.
7
Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma.一名肺腺癌患者出现的与纳武单抗相关的皮肤结节病。
JAAD Case Rep. 2017 Apr 14;3(3):208-211. doi: 10.1016/j.jdcr.2017.02.015. eCollection 2017 May.
8
Eosinophilic Fasciitis and Acute Encephalopathy Toxicity from Pembrolizumab Treatment of a Patient with Metastatic Melanoma.帕博利珠单抗治疗转移性黑色素瘤患者引发嗜酸性筋膜炎及急性脑病毒性
Cancer Immunol Res. 2016 Mar;4(3):175-8. doi: 10.1158/2326-6066.CIR-15-0186. Epub 2016 Jan 28.
9
Eosinophilic fasciitis as a paraneoplastic syndrome, a case report and review of the literature.嗜酸性筋膜炎作为一种副肿瘤综合征：一例报告及文献复习
Hematol Oncol Stem Cell Ther. 2014 Jun;7(2):90-2. doi: 10.1016/j.hemonc.2013.12.003. Epub 2014 Feb 10.
10
Serum levels of tissue inhibitor of metalloproteinase-1 and 2 in patients with eosinophilic fasciitis.嗜酸性筋膜炎患者血清金属蛋白酶组织抑制剂-1和-2水平
Br J Dermatol. 2004 Aug;151(2):407-12. doi: 10.1111/j.1365-2133.2004.06062.x.